Advertisement
Screener

INTERPACE BIOSCIENCES, INC. (IDXG) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings

2.6 / 5 stars · 47/91 Roast Me

INTERPACE BIOSCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings

INTERPACE BIOSCIENCES, INC. (IDXG) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $400.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.

Discontinued › Income Statement › Other Income

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2023-11-08

  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2023-09-30 was $258.00K, a 27.09% increase year-over-year.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2023-06-30 was $175.00K.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2023-03-31 was -$33.00K.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2022-12-31 was $1.26M.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $929.00K.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2021 was -$346.00K.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2020 was -$550.00K.
  • INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2019 was -$323.00K, a 122.91% decline from fiscal 2018.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month
2023-09-30$258.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$433.00K
derived: sum of 2 quarters · filed 2023-11-08
$400.00K
10-Q · filed 2023-11-08
$1.67M
derived: sum of 4 quarters · filed 2023-11-08
2023-06-30$175.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$142.00K
10-Q · filed 2023-08-09
$1.41M
derived: sum of 3 quarters · filed 2023-08-09
$1.61M
derived: sum of 4 quarters · filed 2023-08-09
2023-03-31-$33.00K
10-Q · filed 2023-05-12
$1.23M
derived: sum of 2 quarters · filed 2023-05-12
$1.44M
derived: sum of 3 quarters · filed 2023-05-12
$1.07M
derived: sum of 4 quarters · filed 2023-05-12
2022-12-31$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
$1.47M
derived: sum of 2 quarters · filed 2023-03-27
$1.10M
derived: sum of 3 quarters · filed 2023-03-27
$929.00K
10-K · filed 2023-03-27
2022-09-30$203.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$166.00K
derived: sum of 2 quarters · filed 2022-11-14
-$336.00K
10-Q · filed 2022-11-14
-$762.00K
derived: sum of 4 quarters · filed 2022-11-14
2022-06-30-$369.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$539.00K
10-Q · filed 2022-08-15
-$965.00K
derived: sum of 3 quarters · filed 2022-08-15
-$1.04M
derived: sum of 4 quarters · filed 2022-08-15
2022-03-31-$170.00K
10-Q · filed 2022-05-16
-$596.00K
derived: sum of 2 quarters · filed 2022-05-16
-$668.00K
derived: sum of 3 quarters · filed 2022-05-16
-$500.00K
derived: sum of 4 quarters · filed 2022-05-16
2021-12-31-$426.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$498.00K
derived: sum of 2 quarters · filed 2022-03-31
-$330.00K
derived: sum of 3 quarters · filed 2022-03-31
-$346.00K
10-K · filed 2022-03-31
2021-09-30-$72.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$96.00K
derived: sum of 2 quarters · filed 2021-11-10
$80.00K
10-Q · filed 2021-11-10
-$408.00K
derived: sum of 4 quarters · filed 2021-11-10
2021-06-30$168.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$152.00K
10-Q · filed 2021-08-11
-$336.00K
derived: sum of 3 quarters · filed 2021-08-11
-$349.00K
derived: sum of 4 quarters · filed 2021-08-11
2021-03-31-$16.00K
10-Q · filed 2021-05-11
-$504.00K
derived: sum of 2 quarters · filed 2021-05-11
-$517.00K
derived: sum of 3 quarters · filed 2021-05-11
-$539.00K
derived: sum of 4 quarters · filed 2021-05-11
2020-12-31-$488.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01
-$501.00K
derived: sum of 2 quarters · filed 2021-04-01
-$523.00K
derived: sum of 3 quarters · filed 2021-04-01
-$550.00K
10-K · filed 2021-04-01
2020-09-30-$13.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-01-20
-$35.00K
derived: sum of 2 quarters · filed 2021-01-20
-$62.00K
10-Q · filed 2021-01-20
-$350.00K
derived: sum of 4 quarters · filed 2021-01-20
2020-06-30-$22.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2021-01-19
-$49.00K
10-Q/A · filed 2021-01-19
-$337.00K
derived: sum of 3 quarters · filed 2021-01-19
-$327.00K
derived: sum of 4 quarters · filed 2021-01-19
2020-03-31-$27.00K
10-Q/A · filed 2021-01-19
-$315.00K
derived: sum of 2 quarters · filed 2021-01-19
-$305.00K
derived: sum of 3 quarters · filed 2021-01-19
-$347.00K
derived: sum of 4 quarters · filed 2021-01-19
2019-12-31-$288.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-01-19
-$278.00K
derived: sum of 2 quarters · filed 2021-01-19
-$320.00K
derived: sum of 3 quarters · filed 2021-01-19
-$323.00K
10-K/A · filed 2021-01-19
2019-09-30$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$32.00K
derived: sum of 2 quarters · filed 2019-11-14
-$35.00K
10-Q · filed 2019-11-14
$1.12M
derived: sum of 4 quarters · filed 2019-11-14
2019-06-30-$42.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$45.00K
10-Q · filed 2019-08-13
$1.11M
derived: sum of 3 quarters · filed 2019-08-13
$1.43M
derived: sum of 4 quarters · filed 2019-08-13
2019-03-31-$3.00K
10-Q · filed 2019-05-14
$1.15M
derived: sum of 2 quarters · filed 2019-05-14
$1.47M
derived: sum of 3 quarters · filed 2019-05-14
$1.48M
derived: sum of 4 quarters · filed 2019-05-14
2018-12-31$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21
$1.48M
derived: sum of 2 quarters · filed 2019-03-21
$1.48M
derived: sum of 3 quarters · filed 2019-03-21
$1.41M
10-K · filed 2019-03-21
2018-09-30$325.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$330.00K
derived: sum of 2 quarters · filed 2018-11-14
$259.00K
10-Q · filed 2018-11-14
2018-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$66.00K
10-Q · filed 2018-08-09
2018-03-31-$71.00K
10-Q · filed 2018-05-15
2017-12-31$376.00K
10-K · filed 2018-03-23